| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | T cell receptor binding | 1.15e-05 | 20 | 144 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.99e-05 | 9 | 144 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.99e-05 | 9 | 144 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 4.25e-05 | 10 | 144 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 4.25e-05 | 10 | 144 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 4.25e-05 | 10 | 144 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 7.70e-05 | 12 | 144 | 3 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.32e-04 | 17 | 144 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 4.27e-04 | 49 | 144 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 8.14e-04 | 58 | 144 | 4 | GO:0042287 | |
| GeneOntologyBiologicalProcess | Rab protein signal transduction | 2.68e-07 | 21 | 142 | 5 | GO:0032482 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.74e-05 | 8 | 142 | 3 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.94e-05 | 48 | 142 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | EPHB2 DOCK2 RAPGEF6 RAPGEF4 CHN1 CYRIB CELSR1 RAB4B RAB30 RASGEF1B RAB39A RAB39B RAB4A RASGRP2 | 2.15e-05 | 538 | 142 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 4.92e-05 | 58 | 142 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 5.06e-05 | 139 | 142 | 7 | GO:0019882 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to virus by host | 1.33e-04 | 38 | 142 | 4 | GO:0002230 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.68e-04 | 16 | 142 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.80e-04 | 76 | 142 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.97e-04 | 42 | 142 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 2.02e-04 | 17 | 142 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 2.02e-04 | 17 | 142 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 2.42e-04 | 18 | 142 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.42e-04 | 18 | 142 | 3 | GO:0042590 | |
| GeneOntologyBiologicalProcess | regulation of blastocyst development | 2.80e-04 | 4 | 142 | 2 | GO:0120222 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport postsynaptic membrane to endosome | 2.80e-04 | 4 | 142 | 2 | GO:0098968 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.12e-05 | 7 | 145 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 2.44e-05 | 83 | 145 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.95e-05 | 26 | 145 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 3.79e-05 | 10 | 145 | 3 | GO:0042612 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 5.18e-05 | 11 | 145 | 3 | GO:0032593 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 9.84e-05 | 35 | 145 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 1.13e-04 | 14 | 145 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.19e-04 | 212 | 145 | 8 | GO:0030666 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 2.07e-04 | 17 | 145 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 3.41e-04 | 48 | 145 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | endocytic vesicle | RAPGEF6 STAB2 HLA-B HLA-C HLA-DPB1 HLA-E PIKFYVE RAB43 RAB39A RINL | 3.56e-04 | 384 | 145 | 10 | GO:0030139 |
| GeneOntologyCellularComponent | apolipoprotein B mRNA editing enzyme complex | 4.71e-04 | 5 | 145 | 2 | GO:0030895 | |
| GeneOntologyCellularComponent | Golgi membrane | HLA-B HLA-C HLA-DPB1 HLA-E STING1 RXYLT1 CHST13 PIKFYVE QSOX1 GALNT17 RAB30 WSCD2 RAB39A IL17RD | 5.03e-04 | 721 | 145 | 14 | GO:0000139 |
| GeneOntologyCellularComponent | Golgi medial cisterna | 5.23e-04 | 23 | 145 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 8.04e-04 | 157 | 145 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | mRNA editing complex | 9.81e-04 | 7 | 145 | 2 | GO:0045293 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.02e-03 | 64 | 145 | 4 | GO:0012507 | |
| Domain | RAB | 1.12e-06 | 73 | 138 | 7 | PS51419 | |
| Domain | MHC_I_a_C | 7.77e-06 | 6 | 138 | 3 | IPR010579 | |
| Domain | MHC_I_C | 7.77e-06 | 6 | 138 | 3 | PF06623 | |
| Domain | RasGEFN | 1.26e-05 | 20 | 138 | 4 | SM00229 | |
| Domain | RasGEF_N | 1.55e-05 | 21 | 138 | 4 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.88e-05 | 22 | 138 | 4 | IPR000651 | |
| Domain | RASGEF_NTER | 1.88e-05 | 22 | 138 | 4 | PS50212 | |
| Domain | RASGEF_CAT | 5.87e-05 | 29 | 138 | 4 | PS50009 | |
| Domain | RasGEF | 6.74e-05 | 30 | 138 | 4 | PF00617 | |
| Domain | - | 6.74e-05 | 30 | 138 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 6.74e-05 | 30 | 138 | 4 | IPR001895 | |
| Domain | RasGEF | 6.74e-05 | 30 | 138 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 6.74e-05 | 30 | 138 | 4 | IPR023578 | |
| Domain | Ras | 6.82e-05 | 136 | 138 | 7 | PF00071 | |
| Domain | - | RAB25 TDRD9 RNF213 AK8 SAMD9L MDN1 RAB4B RAB30 RAB43 ERCC6L2 WSCD2 RAB39A RAB39B MYO15A RAB4A AQR | 1.28e-04 | 746 | 138 | 16 | 3.40.50.300 |
| Domain | MHC_I/II-like_Ag-recog | 1.73e-04 | 38 | 138 | 4 | IPR011162 | |
| Domain | P-loop_NTPase | RAB25 TDRD9 RNF213 AK8 SAMD9L SPATA17 MDN1 RAB4B RAB30 RAB43 ERCC6L2 WSCD2 RAB39A RAB39B MYO15A RAB4A AQR | 1.75e-04 | 848 | 138 | 17 | IPR027417 |
| Domain | Small_GTPase | 1.88e-04 | 160 | 138 | 7 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 2.45e-04 | 167 | 138 | 7 | IPR005225 | |
| Domain | MHC_I | 4.76e-04 | 21 | 138 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.76e-04 | 21 | 138 | 3 | IPR001039 | |
| Domain | GLYCOSYL_HYDROL_F1_1 | 5.34e-04 | 5 | 138 | 2 | PS00572 | |
| Domain | Glyco_hydro_1 | 5.34e-04 | 5 | 138 | 2 | PF00232 | |
| Domain | GLYCOSYL_HYDROL_F1_2 | 5.34e-04 | 5 | 138 | 2 | PS00653 | |
| Domain | Glyco_hydro_1 | 5.34e-04 | 5 | 138 | 2 | IPR001360 | |
| Domain | C1-set | 6.78e-04 | 54 | 138 | 4 | PF07654 | |
| Domain | - | 7.13e-04 | 24 | 138 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 7.13e-04 | 24 | 138 | 3 | IPR011161 | |
| Domain | IGc1 | 7.78e-04 | 56 | 138 | 4 | SM00407 | |
| Domain | Ig/MHC_CS | 8.89e-04 | 58 | 138 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 8.89e-04 | 58 | 138 | 4 | IPR003597 | |
| Domain | RASGEF | 9.06e-04 | 26 | 138 | 3 | PS00720 | |
| Domain | IG_MHC | 1.01e-03 | 60 | 138 | 4 | PS00290 | |
| Domain | EGF_LAM_2 | 1.38e-03 | 30 | 138 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.38e-03 | 30 | 138 | 3 | PS01248 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 6.15e-07 | 65 | 108 | 7 | M27771 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 6.15e-07 | 65 | 108 | 7 | MM15511 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 8.60e-06 | 6 | 108 | 3 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.50e-05 | 7 | 108 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.50e-05 | 7 | 108 | 3 | M47530 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.55e-05 | 9 | 108 | 3 | MM14527 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 6.90e-05 | 11 | 108 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.15e-05 | 12 | 108 | 3 | M47529 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.77e-04 | 37 | 108 | 4 | M18615 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.96e-04 | 70 | 108 | 5 | M12294 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.65e-04 | 41 | 108 | 4 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 3.19e-04 | 43 | 108 | 4 | M12617 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.26e-04 | 78 | 108 | 5 | M973 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 3.28e-04 | 18 | 108 | 3 | MM14525 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.12e-04 | 126 | 108 | 6 | M45009 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 4.53e-04 | 20 | 108 | 3 | MM1374 | |
| Pubmed | 4.78e-09 | 16 | 144 | 5 | 32723479 | ||
| Pubmed | 2.12e-08 | 72 | 144 | 7 | 16923123 | ||
| Pubmed | 3.49e-08 | 9 | 144 | 4 | 19180512 | ||
| Pubmed | 9.09e-08 | 11 | 144 | 4 | 22522492 | ||
| Pubmed | 9.09e-08 | 11 | 144 | 4 | 25827531 | ||
| Pubmed | 1.54e-07 | 58 | 144 | 6 | 11856727 | ||
| Pubmed | 2.09e-07 | 61 | 144 | 6 | 12578829 | ||
| Pubmed | 2.30e-07 | 62 | 144 | 6 | 11773082 | ||
| Pubmed | Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. | 2.77e-07 | 4 | 144 | 3 | 25754738 | |
| Pubmed | 2.77e-07 | 4 | 144 | 3 | 17317585 | ||
| Pubmed | 6.91e-07 | 5 | 144 | 3 | 24400003 | ||
| Pubmed | 6.91e-07 | 5 | 144 | 3 | 9754572 | ||
| Pubmed | 6.91e-07 | 5 | 144 | 3 | 21699788 | ||
| Pubmed | APOBEC3 inhibits DEAD-END function to regulate microRNA activity. | 6.91e-07 | 5 | 144 | 3 | 23890083 | |
| Pubmed | Allergic and Nonallergic Asthma Have Distinct Phenotypic and Genotypic Features. | 6.91e-07 | 5 | 144 | 3 | 28380482 | |
| Pubmed | 6.91e-07 | 5 | 144 | 3 | 18486765 | ||
| Pubmed | 1.30e-06 | 20 | 144 | 4 | 12427289 | ||
| Pubmed | Nef performance in macrophages: the master orchestrator of viral persistence and spread. | 1.30e-06 | 20 | 144 | 4 | 22103834 | |
| Pubmed | 1.30e-06 | 20 | 144 | 4 | 9263011 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 16890179 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 10982373 | ||
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 1.38e-06 | 6 | 144 | 3 | 30537346 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 21732917 | ||
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 1.38e-06 | 6 | 144 | 3 | 6420070 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 16866883 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 11932387 | ||
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 1.38e-06 | 6 | 144 | 3 | 6276751 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9730897 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 8671651 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 18958335 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 16019679 | ||
| Pubmed | The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. | 1.38e-06 | 6 | 144 | 3 | 10366557 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 6411351 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9582271 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 1.38e-06 | 6 | 144 | 3 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 1.38e-06 | 6 | 144 | 3 | 3940270 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 7836920 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 8283431 | ||
| Pubmed | QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. | 1.38e-06 | 6 | 144 | 3 | 12389096 | |
| Pubmed | Occurrence of a unique MHC class I gene in distantly related members of the genus Mus. | 1.38e-06 | 6 | 144 | 3 | 3988322 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 12774051 | ||
| Pubmed | Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes. | 1.38e-06 | 6 | 144 | 3 | 2580784 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 2228044 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 6304710 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 6822734 | ||
| Pubmed | Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain. | 1.38e-06 | 6 | 144 | 3 | 26040564 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 28894277 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 3925004 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 20073992 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 10546855 | ||
| Pubmed | The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. | 1.38e-06 | 6 | 144 | 3 | 17726164 | |
| Pubmed | Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. | 1.38e-06 | 6 | 144 | 3 | 6399516 | |
| Pubmed | Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1d. | 1.38e-06 | 6 | 144 | 3 | 6978819 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 10799863 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 14595379 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 19104471 | ||
| Pubmed | HIV immune evasion disruption of antigen presentation by the HIV Nef protein. | 1.38e-06 | 6 | 144 | 3 | 21762823 | |
| Pubmed | Identification of a recombinogenic major histocompatibility complex Q gene with diverse alleles. | 1.38e-06 | 6 | 144 | 3 | 8496692 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 17554059 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 2767053 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 6967411 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9373217 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 7026427 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 19555986 | ||
| Pubmed | The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. | 1.38e-06 | 6 | 144 | 3 | 18976440 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 18976432 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9120272 | ||
| Pubmed | Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex. | 1.38e-06 | 6 | 144 | 3 | 2740345 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 6961454 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 2416805 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9840288 | ||
| Pubmed | A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. | 1.38e-06 | 6 | 144 | 3 | 2789433 | |
| Pubmed | Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells. | 1.38e-06 | 6 | 144 | 3 | 19847956 | |
| Pubmed | Recognition of alternate alleles and mapping of the Qa1 locus. | 1.38e-06 | 6 | 144 | 3 | 7276576 | |
| Pubmed | Repression of MHC class I gene promoter activity by two-exon Tat of HIV. | 1.38e-06 | 6 | 144 | 3 | 8493575 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 8732475 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 22503975 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 9368027 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 11169242 | ||
| Pubmed | Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. | 1.38e-06 | 6 | 144 | 3 | 8877415 | |
| Pubmed | Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. | 1.38e-06 | 6 | 144 | 3 | 18544086 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 11984513 | ||
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 8612235 | ||
| Pubmed | Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? | 1.51e-06 | 47 | 144 | 5 | 19149577 | |
| Pubmed | 1.60e-06 | 21 | 144 | 4 | 8084338 | ||
| Pubmed | 1.95e-06 | 22 | 144 | 4 | 7913356 | ||
| Pubmed | 2.35e-06 | 23 | 144 | 4 | 19770068 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 2592022 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 1705528 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 2808323 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 9586638 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 21088134 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 2.40e-06 | 7 | 144 | 3 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 2.40e-06 | 7 | 144 | 3 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 2.40e-06 | 7 | 144 | 3 | 2714856 | |
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 2.40e-06 | 7 | 144 | 3 | 2391419 | |
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 17900288 | ||
| Pubmed | 2.40e-06 | 7 | 144 | 3 | 15671142 | ||
| Interaction | HLA-H interactions | 4.67e-06 | 17 | 138 | 4 | int:HLA-H | |
| Cytoband | 6p21.3 | 1.52e-04 | 250 | 145 | 6 | 6p21.3 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 3.84e-08 | 65 | 92 | 7 | 388 | |
| GeneFamily | C1-set domain containing | 6.06e-05 | 42 | 92 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 7.29e-05 | 44 | 92 | 4 | 588 | |
| GeneFamily | RNA binding motif containing | 7.66e-04 | 213 | 92 | 6 | 725 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.64e-03 | 12 | 92 | 2 | 406 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 1.93e-03 | 13 | 92 | 2 | 1146 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.14e-03 | 19 | 92 | 2 | 50 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_MICROGLIA | DOCK2 RAPGEF6 MAN2B1 HLA-B HLA-C TMC6 HLA-E RNF213 CCND1 STING1 SLC7A7 LTC4S | 4.33e-06 | 438 | 140 | 12 | M39077 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 7.62e-06 | 24 | 140 | 4 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 9.04e-06 | 25 | 140 | 4 | MM672 | |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN | 9.74e-06 | 193 | 140 | 8 | M6150 | |
| Coexpression | GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 1.26e-05 | 200 | 140 | 8 | M7780 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 1.26e-05 | 200 | 140 | 8 | M6583 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 1.86e-05 | 211 | 140 | 8 | MM17081 | |
| Coexpression | KIM_LRRC3B_TARGETS | 1.92e-05 | 30 | 140 | 4 | M17363 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.95e-05 | 103 | 140 | 6 | MM476 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA | DOCK2 MAN2B1 HLA-B HLA-C HLA-E RNF213 CCND1 STING1 SLC7A7 LTC4S | 3.22e-05 | 371 | 140 | 10 | M39022 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP | HLA-B HLA-C FA2H HLA-E PSMB8 APOBEC3G RNF213 APOBEC3F SAMD9L ADPRM RASGEF1B EXOC3L1 TENT2 | 4.36e-05 | 644 | 140 | 13 | M34026 |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 5.51e-05 | 76 | 140 | 5 | M4551 | |
| Coexpression | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP | 6.77e-05 | 41 | 140 | 4 | M8273 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 7.94e-05 | 16 | 140 | 3 | MM3766 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | DOCK2 MAN2B1 HLA-B TMC6 HLA-E WDR46 PSMB8 RNF213 STING1 SAMD9L RAB4B | 8.25e-05 | 501 | 140 | 11 | M5389 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 9.42e-05 | 85 | 140 | 5 | MM1279 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 9.60e-05 | 17 | 140 | 3 | M1581 | |
| Coexpression | GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP | 9.72e-05 | 198 | 140 | 7 | M4736 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 1.00e-04 | 199 | 140 | 7 | M8100 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN | 1.00e-04 | 199 | 140 | 7 | M7485 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 1.03e-04 | 200 | 140 | 7 | M3638 | |
| Coexpression | GSE3039_NKT_CELL_VS_B2_BCELL_UP | 1.03e-04 | 200 | 140 | 7 | M6435 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.03e-04 | 200 | 140 | 7 | M6625 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN | 1.03e-04 | 200 | 140 | 7 | M6587 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP | 1.03e-04 | 200 | 140 | 7 | M6586 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP | 1.03e-04 | 200 | 140 | 7 | M10032 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 RAPGEF6 TRA2B HLA-B HLA-C HLA-DPB1 TMC6 HLA-E PSMB8 APOBEC3G RNF213 STING1 OGG1 CYRIB APOBEC3F PIKFYVE SAMD9L AKAP11 NSMAF RASGRP2 | 1.33e-04 | 1492 | 140 | 20 | M40023 |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.36e-04 | 19 | 140 | 3 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.36e-04 | 19 | 140 | 3 | MM862 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 1.37e-04 | 49 | 140 | 4 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.59e-04 | 20 | 140 | 3 | MM3682 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 1.84e-04 | 98 | 140 | 5 | MM460 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.85e-04 | 21 | 140 | 3 | MM651 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 2.03e-04 | 100 | 140 | 5 | MM458 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 2.14e-04 | 225 | 140 | 7 | MM17079 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 2.64e-04 | 58 | 140 | 4 | MM661 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | 2.66e-04 | 165 | 140 | 6 | M353 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_B_CELL_AGEING | 2.77e-04 | 311 | 140 | 8 | MM3674 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 2.78e-04 | 24 | 140 | 3 | M4592 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K0 | 1.58e-05 | 122 | 139 | 7 | facebase_RNAseq_e10.5_MaxArch_2500_K0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-08 | 174 | 141 | 8 | 66a3b20ff1ab9f36fb391986444d7dc99d0c03d1 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.78e-07 | 191 | 141 | 8 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-07 | 191 | 141 | 8 | 87b974a320888d63aa8cefcd8dc97d525b56d848 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.85e-07 | 192 | 141 | 8 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 177 | 141 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 177 | 141 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.57e-06 | 177 | 141 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-06 | 177 | 141 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-06 | 177 | 141 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.96e-06 | 183 | 141 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.03e-06 | 184 | 141 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-06 | 185 | 141 | 7 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 192 | 141 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | 3'-Pediatric_IBD|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 195 | 141 | 7 | 728776511e1f40f127f80ef1eecda6d6ad082392 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.09e-06 | 196 | 141 | 7 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.09e-06 | 196 | 141 | 7 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 199 | 141 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-06 | 200 | 141 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-06 | 200 | 141 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 200 | 141 | 7 | 9f1626a7e1bd00977a5c316cafbdf654b52bad94 | |
| ToppCell | COVID-19_Convalescent-CD8+_Tem|COVID-19_Convalescent / Disease condition and Cell class | 3.53e-06 | 200 | 141 | 7 | 1cf2234d5add07e1cd560ca3efa8aafd0851921d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.69e-06 | 130 | 141 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.59e-06 | 135 | 141 | 6 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.06e-06 | 152 | 141 | 6 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-06 | 153 | 141 | 6 | 82a96ca1912858c4311b87b3b0ba5a0a41e564b5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-05 | 161 | 141 | 6 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 165 | 141 | 6 | 50f1fa7434ebb777e15d5273d1ff41070cff6db3 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 166 | 141 | 6 | 971ee6602a1e751f453f9d823295e63dadce62bf | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-05 | 167 | 141 | 6 | 53e32d6687a07f486141df9f4ab998af4c03a507 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.66e-05 | 169 | 141 | 6 | a4204bdd75837f5fee9aaac459cb4c19ee2a7bf4 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 170 | 141 | 6 | ece7c20e89c190a7ec68032b6c2efeb458c43f9a | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 171 | 141 | 6 | 459e1ac0b89571c39db98c0f578eca8f46caa8e3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 172 | 141 | 6 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 1.83e-05 | 172 | 141 | 6 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-05 | 173 | 141 | 6 | b06d6e7acb7086bb99600b680cf404c0ef06b52c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.08e-05 | 176 | 141 | 6 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.08e-05 | 176 | 141 | 6 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 2.15e-05 | 177 | 141 | 6 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 2.22e-05 | 178 | 141 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 182 | 141 | 6 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 182 | 141 | 6 | 8d8f28bd43108b2fb3a6c2a3d77a897853d440a4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 183 | 141 | 6 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 183 | 141 | 6 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 183 | 141 | 6 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 184 | 141 | 6 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 186 | 141 | 6 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.84e-05 | 186 | 141 | 6 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.84e-05 | 186 | 141 | 6 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 186 | 141 | 6 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.84e-05 | 186 | 141 | 6 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.93e-05 | 187 | 141 | 6 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | 74112df9b34051ae5cd2427ccfa3399eccff0076 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.93e-05 | 187 | 141 | 6 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | a555a4af7946dec14a6b176ace4a4c2ecfd7f59e | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | 214ce9b55fd6ce2fe7bd4cf4b1383517f5f0d759 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|(2)_5-FU / Stress and Cell class | 3.11e-05 | 189 | 141 | 6 | 0f169b17bb26a812a5b0dcd6e29a3ca8415fd197 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 190 | 141 | 6 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.30e-05 | 191 | 141 | 6 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-05 | 191 | 141 | 6 | 9774d423e448ec2d415261e4ad386a81558129b3 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.30e-05 | 191 | 141 | 6 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-05 | 192 | 141 | 6 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 192 | 141 | 6 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-05 | 192 | 141 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 192 | 141 | 6 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.39e-05 | 192 | 141 | 6 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 193 | 141 | 6 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 3.49e-05 | 193 | 141 | 6 | 51fd629e91c85881c3231486d6d2fb2c65fcd77b | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 3.60e-05 | 194 | 141 | 6 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-05 | 194 | 141 | 6 | 4eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.60e-05 | 194 | 141 | 6 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.60e-05 | 194 | 141 | 6 | 68a9e00c9e1a855eeebfc26c038652f3800758db | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TEM|IIF / Disease, Lineage and Cell Type | 3.60e-05 | 194 | 141 | 6 | f4f7c85963ba52ee7ca2ef5657e60680fe6332fe | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.60e-05 | 194 | 141 | 6 | fa53f1aab2f5923e90f090e10e3560b583441dc4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.60e-05 | 194 | 141 | 6 | 11eb317f66cbced1cedadd6daba443c4d832c49f | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.60e-05 | 194 | 141 | 6 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|erythropoietic / Lineage and Cell class | 3.70e-05 | 195 | 141 | 6 | cd3d8fa6e18c0508cdfb64bb879d90b211badee5 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 3.70e-05 | 195 | 141 | 6 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | medial-2-Hematologic-IGSF21+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-05 | 195 | 141 | 6 | bb612979360b2322289545dda3d3c343d005ee6f | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 3.70e-05 | 195 | 141 | 6 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.70e-05 | 195 | 141 | 6 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 195 | 141 | 6 | 7533822d2fe551f499b5b2fdec7172f56c79cb44 | |
| ToppCell | medial-Hematologic-IGSF21+_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-05 | 195 | 141 | 6 | 779130c2cfcbc603955b0c0332b855b22ab6e9e6 | |
| ToppCell | medial-Hematologic-IGSF21+_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.70e-05 | 195 | 141 | 6 | 330b688d703d53cb7feb29373b5a6e6e529169ec | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.71e-05 | 118 | 141 | 5 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 3.81e-05 | 196 | 141 | 6 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | severe-CD8+_Tem|severe / disease stage, cell group and cell class | 3.81e-05 | 196 | 141 | 6 | 9456a5879948e25bc483a7233c274da841ef2c68 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 196 | 141 | 6 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.81e-05 | 196 | 141 | 6 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 196 | 141 | 6 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.81e-05 | 196 | 141 | 6 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 196 | 141 | 6 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.81e-05 | 196 | 141 | 6 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 197 | 141 | 6 | 77107345c766451302e21f7cbd45316f4131a0e8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-05 | 197 | 141 | 6 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 3.92e-05 | 197 | 141 | 6 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-05 | 197 | 141 | 6 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 3.92e-05 | 197 | 141 | 6 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| Computational | Neighborhood of CD48 | 2.35e-06 | 32 | 74 | 5 | GNF2_CD48 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.24e-05 | 50 | 74 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Neighborhood of CD53 | 4.65e-05 | 58 | 74 | 5 | GNF2_CD53 | |
| Computational | Genes in the cancer module 293. | 6.59e-05 | 12 | 74 | 3 | MODULE_293 | |
| Computational | Neighborhood of VAV1 | 1.03e-04 | 36 | 74 | 4 | GNF2_VAV1 | |
| Computational | Genes in the cancer module 143. | 1.08e-04 | 14 | 74 | 3 | MODULE_143 | |
| Computational | Neighborhood of STAT6 | 2.05e-04 | 79 | 74 | 5 | GNF2_STAT6 | |
| Computational | Neighborhood of INPP5D | 2.08e-04 | 43 | 74 | 4 | GNF2_INPP5D | |
| Computational | Neighborhood of PTPN6 | 2.95e-04 | 47 | 74 | 4 | GNF2_PTPN6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.75e-04 | 50 | 74 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Neighborhood of ATM | 1.11e-03 | 30 | 74 | 3 | GNF2_ATM | |
| Computational | Neighborhood of TERF1 | 1.14e-03 | 67 | 74 | 4 | MORF_TERF1 | |
| Disease | occupational asthma (is_implicated_in) | 3.57e-07 | 4 | 133 | 3 | DOID:0080820 (is_implicated_in) | |
| Disease | allergic asthma (is_implicated_in) | 8.89e-07 | 5 | 133 | 3 | DOID:9415 (is_implicated_in) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 3.09e-06 | 7 | 133 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | DNA dC->dU-editing enzyme APOBEC-3G measurement | 6.03e-05 | 3 | 133 | 2 | EFO_0802473 | |
| Disease | COVID-19 (is_implicated_in) | 1.12e-04 | 21 | 133 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 2.42e-04 | 27 | 133 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | Myasthenia Gravis | 2.99e-04 | 6 | 133 | 2 | C0026896 | |
| Disease | Myasthenia Gravis, Ocular | 2.99e-04 | 6 | 133 | 2 | C0751340 | |
| Disease | Myasthenia Gravis, Generalized | 2.99e-04 | 6 | 133 | 2 | C0751339 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 3.32e-04 | 30 | 133 | 3 | C1868672 | |
| Disease | Mental Retardation, X-Linked 1 | 4.04e-04 | 32 | 133 | 3 | C2931498 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 4.42e-04 | 33 | 133 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | cervical cancer | 4.84e-04 | 34 | 133 | 3 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 5.27e-04 | 35 | 133 | 3 | C0007873 | |
| Disease | Urologic Neoplasms | 5.55e-04 | 8 | 133 | 2 | C0042076 | |
| Disease | Cancer of Urinary Tract | 5.55e-04 | 8 | 133 | 2 | C0751571 | |
| Disease | Hepatitis B, Chronic | 5.55e-04 | 8 | 133 | 2 | C0524909 | |
| Disease | Carcinoma, Transitional Cell | 8.42e-04 | 41 | 133 | 3 | C0007138 | |
| Disease | beta-2 microglobulin measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0005197 | |
| Disease | bipolar disorder | 1.25e-03 | 577 | 133 | 9 | MONDO_0004985 | |
| Disease | dermatomyositis | 1.29e-03 | 12 | 133 | 2 | EFO_0000398 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.52e-03 | 13 | 133 | 2 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.52e-03 | 13 | 133 | 2 | C0002514 | |
| Disease | Asthma, Aspirin-Induced | 1.52e-03 | 13 | 133 | 2 | C1319853 | |
| Disease | dystonia (is_implicated_in) | 1.77e-03 | 14 | 133 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Malignant neoplasm of prostate | 1.96e-03 | 616 | 133 | 9 | C0376358 | |
| Disease | liver neoplasm | 2.04e-03 | 15 | 133 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 2.04e-03 | 15 | 133 | 2 | EFO_0006927 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 2.04e-03 | 15 | 133 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0801746 | |
| Disease | adverse effect, response to xenobiotic stimulus | 2.42e-03 | 59 | 133 | 3 | EFO_0009658, GO_0009410 | |
| Disease | serum IgG glycosylation measurement | 2.62e-03 | 523 | 133 | 8 | EFO_0005193 | |
| Disease | Moyamoya Disease | 2.62e-03 | 17 | 133 | 2 | C0026654 | |
| Disease | acute pancreatitis | 2.94e-03 | 18 | 133 | 2 | EFO_1000652 | |
| Disease | unipolar depression | B4GALNT4 HLA-B TDRD9 HLA-E RNF213 AK8 TUBGCP6 AGBL4 GALNT17 RASGEF1B MKLN1 MED12 CRTAP | 3.20e-03 | 1206 | 133 | 13 | EFO_0003761 |
| Disease | hepatitis B virus infection | 3.28e-03 | 19 | 133 | 2 | EFO_0004197 | |
| Disease | Neoplasms, Experimental | 3.33e-03 | 66 | 133 | 3 | C0027659 | |
| Disease | Prostate cancer, familial | 3.78e-03 | 69 | 133 | 3 | C2931456 | |
| Disease | thyroid peroxidase antibody measurement | 4.26e-03 | 72 | 133 | 3 | EFO_0005666 | |
| Disease | perceived unattractiveness to mosquitos measurement | 4.26e-03 | 72 | 133 | 3 | EFO_0008380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSQRGYYLTLRANRV | 111 | B0FP48 | |
| FYRPEQLARLGQYRS | 41 | Q86VI1 | |
| ETGQGYQRFLLYNRS | 136 | O95445 | |
| LRPRVNYLQDFSYQR | 201 | Q9UKH3 | |
| QLRRYTAQLLSGLDY | 401 | Q9P2K8 | |
| TFSYNFYNRPILSRR | 16 | Q9HC16 | |
| DRYQSVIYPFLSQRR | 141 | P50052 | |
| AFNGTQRFLERYIYN | 46 | P04440 | |
| NSYGLYTIRDRENRT | 401 | Q86Y34 | |
| QYANRLAYRSVKSGL | 1366 | Q9UKA4 | |
| LEDGFNFQGTRRRYY | 31 | Q3LIE5 | |
| NFQGTRRRYYRHSLL | 36 | Q3LIE5 | |
| RTQGLFSYREDYRTQ | 821 | Q9P1A6 | |
| VGIRNTFLLRTYAYL | 286 | Q6PIY7 | |
| DFSRYGRVNYVLARR | 891 | O60306 | |
| NNFLSYYRLTRFLSR | 221 | P24385 | |
| RLQYFARGLQVYIRQ | 376 | Q9BZZ5 | |
| EGYFSNVARNVRRTY | 2221 | Q9NYQ6 | |
| RGRIYYAKFINTNAR | 46 | Q8N5S3 | |
| ISVRNALRRYYLNGH | 786 | Q8TE57 | |
| LERYRAITSAYYRGA | 71 | P57735 | |
| GQERFRSITRSYYRN | 71 | Q14964 | |
| AGQERFRSITRAYYR | 66 | Q96DA2 | |
| FRSITRAYYRNSVGG | 71 | Q96DA2 | |
| SLRHYLNLVTRQRYG | 51 | P10082 | |
| AGQERFRSITQSYYR | 66 | Q15771 | |
| GQERFRTITQSYYRS | 76 | Q86YS6 | |
| GQERFRSVTRSYYRG | 71 | P20338 | |
| GQERFRSVTRSYYRG | 66 | P61018 | |
| RSFYTAYLQRLSGLT | 256 | O00391 | |
| GGARIQVFLARYSYN | 651 | O95153 | |
| LYTYSGLRNRRAAVY | 71 | Q8N684 | |
| NRYERAIYAALSGNL | 421 | P57740 | |
| RLYYLRNGERISVSA | 136 | P28062 | |
| RRNFGYTLRSVNDLY | 211 | P05546 | |
| YGRSLRYAALNLAAL | 296 | Q9UJX4 | |
| TYRCQTARYNGFNVR | 511 | Q8NFP4 | |
| RVNLRTLRGYYNQSE | 96 | P13747 | |
| DAILYYYQSGGRLRR | 86 | P16389 | |
| YGYRRLLRFSTQIYN | 576 | Q96JB6 | |
| AEQESGLYRYRSRNS | 3546 | Q9NU22 | |
| ERRAYSNLGNAYIFL | 241 | P81274 | |
| RNYFRSKSGRSLYVA | 531 | Q8NFM7 | |
| YNQRRKGTNRIFYSD | 2231 | Q9NZR2 | |
| QRYRSLFLSGSKRYL | 371 | Q3ZCV2 | |
| FFRRVRASYYVVSGN | 2711 | P78559 | |
| ALTLRGINSFRQYKY | 316 | O43292 | |
| YGNYRRRLAACVGFR | 286 | Q7LDG7 | |
| LLQSRARGYLARQRY | 1931 | Q9UKN7 | |
| GRYFEHYRSIININR | 276 | Q5FYB0 | |
| FQVRARTVAGYGRYS | 506 | P29323 | |
| GRQTYDYRNIRISFG | 26 | Q06265 | |
| QADRVSLRNLRGYYN | 96 | P10321 | |
| FSYTATEARRLYLQR | 96 | Q96MA6 | |
| LLLRRGNIFLTSYQY | 596 | O15031 | |
| LRYFQGYARSAQLRL | 91 | Q16873 | |
| AYLYARFNRISRIRA | 156 | Q9UBM4 | |
| ILYAALNRDFRTGYQ | 286 | P25021 | |
| LTGNSKYIYRAQRFA | 356 | Q6ZV70 | |
| NTNRPRTARASARYY | 1341 | P09848 | |
| LRYSGEFVQSAYLSR | 281 | Q93074 | |
| AFTSGLRRYLQYYRA | 431 | Q96RT7 | |
| FHLRRNRGVYIIQSY | 241 | O14764 | |
| LGYRARYVSASARAI | 201 | O15527 | |
| VATRRSLGYAYINFQ | 46 | Q4VXU2 | |
| YNYRTALRGAAQRSL | 346 | Q0VAM2 | |
| QTDRESLRNLRGYYN | 96 | P01889 | |
| NRYTNILPYDFSRVR | 966 | Q16827 | |
| QDLNRNRVYFYGRRE | 126 | P0DTF9 | |
| LYASALYRQRRSGRA | 156 | Q92914 | |
| SYYRTFAQGNVRLFT | 186 | Q7L5A8 | |
| FPRARYRARTTNYNS | 261 | Q86U42 | |
| QGGRRLYSRYVSNRN | 21 | Q9P2J9 | |
| YVLFRSIQRSRAGYC | 361 | P81408 | |
| RRLIRTYQLYSRTSG | 66 | P55075 | |
| LELRFYGHQYTRRAN | 1341 | Q9Y2I7 | |
| TFSYNFYNRPILSRR | 16 | Q8IUX4 | |
| RVAGNTAYYQLRDRV | 691 | Q9P2N4 | |
| HRTRRYTLFNNGTLY | 2091 | Q6WRI0 | |
| STALNRGEQRAVRYY | 6 | Q8N954 | |
| NRNSRRGITYNYVIS | 76 | Q13609 | |
| SNYVQRFHYSRPVRR | 1436 | Q92608 | |
| GGRRTYFLQIRYYLS | 861 | Q9H799 | |
| LRPRVNYLQDFSYQR | 91 | P61567 | |
| LRAGRAQYERYSFRS | 21 | O75718 | |
| VRGYDFNRGVNYRAL | 31 | P49366 | |
| ALLFRSARQYVYGVL | 651 | Q9NX05 | |
| ILRNFYFINRLTGYL | 171 | P01574 | |
| TFRKLYARIRQGNYS | 261 | Q3MIR4 | |
| LGRNVARTFLDYYRL | 426 | Q5VU57 | |
| YNSNIGFYTKRNALR | 386 | Q6IS24 | |
| LRPRVNYLQDFSYQR | 201 | P61565 | |
| LRPRVNYLQDFSYQR | 91 | Q9HDB8 | |
| FLNVATAQGRYYRTN | 296 | O00754 | |
| AYARYSSRRGAQAAI | 101 | Q8IYX4 | |
| VYFYSIAFGRRQDTL | 696 | Q92636 | |
| GYSNRLYFVNLRTRD | 91 | Q8N7A1 | |
| NRQALRYYRCVVSEG | 616 | Q86Z14 | |
| RNLTALRIRATYGEY | 341 | Q13753 | |
| AIQNDFSYYRRTLSR | 151 | Q9NUQ9 | |
| RRNGFRRQEQSVYYL | 546 | Q9ULB5 | |
| NRYLRDYQREGTRFL | 131 | Q5T890 | |
| LRFGSQTRNFRLYYD | 86 | P15882 | |
| SAYGIYILDRRFRSL | 546 | P13807 | |
| LYAAYHVFFGRRRQA | 21 | Q9Y2B1 | |
| QLLYYLQNRRDSLSG | 91 | Q92845 | |
| LGVYTRNRNFRLYKS | 281 | Q96LW4 | |
| VTRRSLGYAYVNFLQ | 46 | P0CB38 | |
| RLQARSSTVGNQYYF | 6 | Q96L03 | |
| NTARTVRYYRSQPFN | 956 | Q8WZA2 | |
| YNNLLRGAVSQRLYI | 186 | Q86WV6 | |
| FSQRGYYLTLRANRV | 111 | E5RIL1 | |
| ARARYERYSGNQVLF | 51 | Q8TEU7 | |
| LARLFTAYLQLYRGF | 781 | O95602 | |
| QRYFRAQVLYVSGNS | 961 | Q8NDG6 | |
| QRRQIYTLGRYLDSS | 336 | Q9UL63 | |
| YVSSLNRSFRGQYKR | 1451 | Q8IVG5 | |
| ATVGYFIFYSARRLR | 221 | Q8TEB7 | |
| NLTSLRRLYLNGNYL | 421 | Q9H156 | |
| QILQREGTRALYRGY | 231 | Q8N5S1 | |
| RTRQITRYRNGDAYT | 161 | Q8N4L1 | |
| GDRTRRSYYLNEIQS | 171 | Q9H0A9 | |
| GIRFCTNRRSALYYV | 271 | P13798 | |
| AARLPRYQYLRRTGN | 876 | Q76KP1 | |
| RYQYLRRTGNFERSA | 881 | Q76KP1 | |
| NKLARPYSAAFQRRY | 186 | Q8NET6 | |
| FGRNYSLSVYLVRQL | 266 | Q9Y6X2 | |
| LVRARSSYVARQYRS | 266 | Q6ZS11 | |
| SETFQRPYQYLRRFN | 2161 | Q63HN8 | |
| LERASQYNIRGVTYR | 286 | Q8TBC4 | |
| GNQTAAIRYYREAVR | 496 | Q5T4D3 | |
| IRNRGYNLIYRSTRH | 121 | Q8IY95 | |
| RAYQYLRPGSSYALR | 421 | Q2M3V2 | |
| RSNDYFVLQRRRGYG | 21 | Q0IIM8 | |
| GISALRRVLTAYAYR | 551 | Q0IIM8 | |
| TGRQINDYLRRQTYG | 176 | Q86U17 | |
| FRLRFRQFRYQEAAG | 41 | Q6NSZ9 | |
| YLRRIVGSATRYLQV | 471 | Q9UM01 | |
| VYSRIPNLSRRFQYR | 371 | P78562 | |
| YFHRTFVYSLLNRGR | 91 | P31213 | |
| ALAAYSYFRINRRTI | 2476 | Q8WWQ8 | |
| LDGARFRYLNEQLYS | 246 | O43159 | |
| QQGLASYDYVRRRLT | 3771 | Q15149 | |
| IYFIRSINAYRATLG | 321 | Q6PF05 | |
| LYNSQLLFRSRLYGD | 311 | Q6ZUG5 | |
| RGRAYFYALLNVLSI | 101 | P0C7Q6 | |
| LNLRQFGPYRLNYSR | 191 | O15213 | |
| RRAQQIAQLYGRLYS | 36 | Q9NQZ5 | |
| IAQLYGRLYSESSRR | 41 | Q9NQZ5 | |
| GRSRGAIISQYYNRT | 91 | Q7Z403 | |
| ALIRQNGIRRLGYTY | 46 | Q8N6G2 | |
| YRLQLAQESARRYGS | 216 | Q2TBF2 | |
| LFNSTLLYRRSSYRQ | 111 | Q14679 | |
| YDQQSRRSRGFAFVY | 151 | P62995 |